What does Eli Lilly's uncertain future spell for Elanco?
While Elanco has gone from strength to strength in recent years, its parent company Eli Lilly has not fared as well. A recent article in the Financial Times suggested Eli Lilly could be the target of a takeover. So is this good or bad news for Elanco? Animal Pharm Editor Joseph Harvey weighs up the company's options.